CAS 199807-33-5

Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA

Description:

Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA is a cyclic peptide that incorporates a sequence known for its role in cell adhesion and interaction with integrins, particularly in the context of biological processes such as wound healing and tissue regeneration. The cyclic structure enhances its stability and bioactivity compared to linear peptides. The presence of the amino acids arginine (Arg), glycine (Gly), aspartic acid (Asp), D-phenylalanine (D-Phe), and valine (Val) contributes to its specific binding properties and potential therapeutic applications. The TFA (trifluoroacetic acid) salt form indicates that the peptide is likely used in research or pharmaceutical contexts, where it may be employed in drug delivery systems or as a targeting moiety in cancer therapy. Its characteristics include solubility in polar solvents, stability under physiological conditions, and the ability to mimic natural ligand interactions, making it a valuable tool in biochemistry and molecular biology.

Formula: C₂₈H₃₉F₃N₈O₉

Synonyms:

• Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA

Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA

CAS: 199807-33-5

Arg-Gly-Asp-D-Phe-Val (TFA) has anti-tumor activity and is an inhibitor of integrin αvβ3.

Formula: C₂₈H₃₉F₃N₈O₉

Purity: 98%

Color and Shape: Solid

Molecular weight: 688.662

Ref: TM-T10920

Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA

CAS: 199807-33-5

Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA is a cyclic peptide, which is a synthetic analog often used in biochemical research. It is derived from a sequence known to be a core recognition motif for integrins, particularly the RGD binding integrins. This synthetic peptide is synthesized using solid-phase peptide synthesis techniques, allowing precise control over its structure and stereochemistry.

Formula: C₂₈H₃₉F₃N₈O₉

Purity: Min. 95%

Molecular weight: 688.7 g/mol

Ref: 3D-ZHA80733